1. Home
  2. Labeler Index
  3. Bryant Ranch Prepack
  4. 63629-1200
  5. Product Images: Simvastatin

Product Images Simvastatin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 12 images provide visual information about the product associated with Simvastatin NDC 63629-1200 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Footnote for Table 3 - Footnote for Table 3

Footnote for Table 3 - Footnote for Table 3

This text provides information on the effects of various inhibitors on simvastatin pharmacokinetics, as well as the use of grapefruit juice in combination with simvastatin. It notes that the results are based on a chemical assay, and the use of propranolol is indicated. Double-strength and single-strength grapefruit juice were administered in different dosages over several days, with simvastatin administered on Day 3. The text also clarifies that simvastatin acid refers to the p-hydroxyacid of simvastatin.*

Label - lbl636291200

Label - lbl636291200

This is a description of a medication called NILD, which is a Simvastatin Tablet. Each tablet of the medication contains 80mg of Simvastatin. The medication needs to be stored in a tight, light-resistant container with a child-resistant closure, and kept out of the reach of children. The tablets need to be stored at a temperature between 20° to 25°C (68° to 77°F). The medication is available in a package of 1000 tablets. The description includes a VSN number and an NDC number.*

Figure 9 - simvastatin 10

Figure 9 - simvastatin 10

table2 - simvastatin 2

table2 - simvastatin 2

The text describes adverse reactions reported for patients treated with Simvastatin and Placebo. The table shows a comparison of the frequency of these reactions between the two groups. The reactions are categorized by system disorders such as cardiovascular, digestive, endocrine, musculoskeletal, nervous system/psychiatric, respiratory, skin/skin appendage, and urogenital system disorders. The adverse reactions with a frequency of 2% or more of the patients treated with Simvastatin and greater than placebo in 45 are listed in the table. These include edema/swelling, abdominal pain, atrial fibrillation, constipation, gastritis, diabetes mellitus, myalgia, headache, insomnia, vertigo, bronchitis, sinusitis, eczema, and urinary tract infection.*

Structure - simvastatin 3

Structure - simvastatin 3

table 3 - simvastatin 4

table 3 - simvastatin 4

table 4 - simvastatin 5

table 4 - simvastatin 5

Figure 5 - simvastatin 6

Figure 5 - simvastatin 6

Figure 6 - simvastatin 7

Figure 6 - simvastatin 7

Figure 7 - simvastatin 8

Figure 7 - simvastatin 8

The provided text is not readable.*

Figure 8 - simvastatin 9

Figure 8 - simvastatin 9

table 1 - table1

table 1 - table1

This is a table showing various drug interactions that are associated with an increased risk of myopathy or rhabdomyolysis. The table lists several interacting agents and prescribing recommendations for them. Some of the drugs that are recommended to avoid or use with caution include strong CYP3A4 inhibitors, HIV protease inhibitors, amiodarone, lomitapide, and daptomycin. It also notes not to exceed a certain daily dose of simvastatin when using certain drugs like verapamil or amiodarone. There is a mention to avoid grapefruit juice when taking certain medications. However, towards the end, the text becomes unclear and non-readable, therefore, it's not possible to assess its meaning.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.